Overview

SPD544 High Strength Bioequivalence Study

Status:
Completed
Trial end date:
2010-10-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess bioequivalence of 2 capsule strengths.
Phase:
Phase 1
Details
Lead Sponsor:
Shire
Treatments:
Methylphenidate